DANBURY, Conn., July 26, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has ...
Arecor Therapeutics plc has presented early stage clinical data from a novel concentrated insulin formulation, which it hopes will outperform marketed rivals by allowing lower volume and reduced ...
The JDRF, a global research foundation focused on Type 1 diabetes, and Arecor said they are partnering to advance preclinical trials of the U.K.-based formulation company’s ultraconcentrated insulin.
The authors acknowledge the assistance of Oswaldo Bracco, M.D., and Dennis Brinker, Pharm.D., in providing the LSS data presented; Samuel L. Ellis, Pharm.D., BCPS ...
Becton Dickinson launched a new syringe specifically for use with Eli Lilly’s concentrated insulin, which is prescribed for diabetics who need to inject higher doses of insulin daily. Previously, ...
WESTFIELD, Ind., Feb. 17, 2026 /PRNewswire/ -- Today, Portal Diabetes, Inc. ("Portal") announced its receipt of the Breakthrough Device Designation by the Food and Drug Administration (FDA) for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results